Institutional Ownership Prime Medicine, Inc. (PRME)
This table provides information about the institutional ownership of Prime Medicine, Inc. (PRME). We have compiled data on the 136 institutions that hold shares in the stock, with a total of 63.3 Million shares, which have been reported (via 13F filing form) to have a value of $162 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Farther Finance Advisors, LLC
San Francisco, CA |
Feb 07, 2025 Q4 2024 |
26
shares
|
$66
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Lazard Asset Management LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
26
shares
|
$66
0.0% of portfolio
|
Q3 2024
Reduced 63.89%
|
|
|
Ifp Advisors, Inc
|
Feb 04, 2025 Q4 2024 |
24
shares
|
$61
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Covestor LTD
Boston, MA |
Feb 13, 2025 Q4 2024 |
14
shares
|
$35
0.0% of portfolio
|
Q4 2024
Added 7.69%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Feb 13, 2025 Q4 2024 |
6
shares
|
$15
0.0% of portfolio
|
Q4 2024
Added 50.0%
|
|
|
Ever Source Wealth Advisors, LLC
|
Feb 07, 2025 Q4 2024 |
6
shares
|
$15
0.0% of portfolio
|
Q4 2024
Reduced 94.34%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|